Sec Form 13D Filing - Atwood Brent @ GLOBESTAR THERAPEUTICS CORP

Insider filing report for Changes in Beneficial Ownership

Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
_______________

SCHEDULE 13D/A

(Amendment No. 1)

Under the Securities Exchange Act of 1934

ANGIOSOMA INC.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

03476L102

(CUSIP Number)

Brent Atwood

5000 Riverside Drive

Ste 100E Bldg 6

Irving, Texas 75039

Telephone: (907) 738-8458

With a copy to:

John Cooley

5000 Riverside Drive

Ste 100E Bldg 6

Irving, Texas 75039

Telephone: (972) 974-8979

(Name, Address and Telephone Number of Person Authorized to

Receive Notices and Communications)

February 25, 2020

Date of Event Which Requires Filing of This Statement)

_______________

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. [ ]

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes)

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Brent Atwood

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	United States of America

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-

	8	SHARED VOTING POWER
		-0-

	9	SOLE DISPOSITIVE POWER
		-0-

	10	SHARED DISPOSITIVE POWER
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)	[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*
	0.0%*
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	IN
	IN

___________________

* Calculated based on 225,634,365 shares of Common Stock issued and outstanding as of February 14, 2020, as reported in the Issuer's Quarterly Report on Form 10-Q filed on February 14, 2020 for the quarterly period ended December 31, 2019.

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Equine Holdings, LLC
	Equine Holdings, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)	[X]
		(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)		[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming
	Wyoming

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-
		-0-
	8	SHARED VOTING POWER
		-0-
		-0-
	9	SOLE DISPOSITIVE POWER
		-0-
		-0-
	10	SHARED DISPOSITIVE POWER
		-0-
		-0-
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-
	-0-
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)		[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*
	0.0%*
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	EQuine Holdings Charter Private Equity Fund XIII 13

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	< p>CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-

	8	SHARED VOTING POWER
		-0-

	9	SOLE DISPOSITIVE POWER
		-0-

	10	SHARED DISPOSITIVE POWER
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)			[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Equine Charter Private Equity Fund XX
	Equine Charter Private Equity Fund XX

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-

	8	SHARED VOTING POWER
		-0-

	9	SOLE DISPOSITIVE POWER
		-0-

	10	SHARED DISPOSITIVE POWER
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)			[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Equine Charter Private Equity Fund XI

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-

	8	SHARED VOTING POWER
		-0-

	9	SOLE DISPOSITIVE POWER
		-0-

	10	SHARED DISPOSITIVE POWER
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)	[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Equine Charter Private Equity Fund XII
	Equine Charter Private Equity Fund XII
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming
	Wyoming
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-
		-0-
	8	SHARED VOTING POWER
		-0-
		-0-
	9	SOLE DISPOSITIVE POWER
		-0-
		-0-
	10	SHARED DISPOSITIVE POWER
		-0-
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-
	-0-
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)	[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*
	0.0%*
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Equine Charter Private Equity Fund XV

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-

	8	SHARED VOTING POWER
		-0-

	9	SOLE DISPOSITIVE POWER
		-0-

	10	SHARED DISPOSITIVE POWER
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)			[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

___________________

CUSIP No. 03476L102

1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	eQuine Charter Private Equity Fund DCCCLXXXVIII, LLC

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-
			< p>
	8	SHARED VOTING POWER
		-0-

	9	SOLE DISPOSITIVE POWER
		-0-

	10	SHARED DISPOSITIVE POWER
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)			[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	eQuine Charter Private Equity Fund VII, LLC
	eQuine Charter Private Equity Fund VII, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming
	Wyoming
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-
		-0-
	8	SHARED VOTING POWER
		-0-
		-0-
	9	SOLE DISPOSITIVE POWER
		-0-
		-0-
	10	SHARED DISPOSITIVE POWER
		-0-
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-
	-0-
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)	[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*
	0.0%*
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	eQuine Private Equity Fund 755460, LLC
	eQuine Private Equity Fund 755460, LLC
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP	(a)	[X]
		(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO
	OO
5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)		[ ]

6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming
	Wyoming
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-
		-0-
	8	SHARED VOTING POWER
		-0-
		-0-
	9	SOLE DISPOSITIVE POWER
		-0-
		-0-
	10	SHARED DISPOSITIVE POWER
		-0-
		-0-
11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-
	-0-
12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)		[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*
	0.0%*
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	Goddard Investment Company PE Fund XIX

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-

	8	SHARED VOTING POWER
		-0-

	9	SOLE DISPOSITIVE POWER
		-0-

	10	SHARED DISPOSITIVE POWER
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)	[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*
	0.0%*
14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO
	OO

___________________

CUSIP No. 03476L102
1	NAMES OF REPORTING PERSONS
	I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
	EQuine Private Equity Fund LXXVII (77) LLC

2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP		(a)	[X]
			(b)	[ ]

3	SEC USE ONLY


4	SOURCE OF FUNDS (SEE INSTRUCTIONS)
	OO

5	CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(D) OR 2(E)			[ ]


6	CITIZENSHIP OR PLACE OF ORGANIZATION
	Wyoming

NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH	7	SOLE VOTING POWER
		-0-

	8	SHARED VOTING POWER
		-0-

	9	SOLE DISPOSITIVE POWER
		-0-

	10	SHARED DISPOSITIVE POWER
		-0-

11	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
	-0-

12	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)			[ ]


13	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
	0.0%*

14	TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
	OO

___________________

SCHEDULE 13D

This Amendment No. 1 (this "Amendment") to the Statement on Schedule 13D is filed by the Reporting Persons as an amendment to the Schedule 13D filed on August 21, 2019 with the U.S. Securities and Exchange Commission (the "SEC") (together, the "Schedule 13D") with respect to the common shares of AngioSoma Inc. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Schedule 13D.

This is the final amendment to the Schedule 13D and constitutes an "exit" filing for the Reporting Persons.

Item 1. Security and Issuer

This Schedule 13D relates to the common shares (the "Common Shares") of AngioSoma Inc. (the "Issuer"), a Wyoming corporation. The address of the Issuer's principal executive offices is 2500 Wilcrest Drive, 3rd Floor, Houston, TX 77042.

Item 2. Identity and Background

(a)

This Statement is being filed by Brent Atwood ("Atwood"), Equine Holdings, LLC, a Wyoming limited liability company ("Holdings"), Equine Holdings Charter Private Equity Fund XIII 13 ("XIII"), a Wyoming limited liability company, Equine Charter Private Equity Fund XX, a Wyoming limited liability company ("XX"), Equine Charter Private Equity Fund XI, a Wyoming limited liability company ("XI"), Equine Charter Private Equity Fund XII, a Wyoming limited liability company ("XII"), eQuine Charter Private Equity Fund XV, LLC, a Wyoming limited liability company ("XV"), eQuine Charter Private Equity Fund DCCCLXXXVIII, LLC, a Wyoming limited liability company ("888"), eQuine Charter Private Equity Fund VII, LLC, a Wyoming limited liability company ("VII"), eQuine Private Equity Fund 755460, LLC, a Wyoming limited liability company ("755460"), and Cargill - Atwood Family Private Equity Fund, LLC, a Wyoming limited liability company ("CA" and, collectively, the "Reporting Persons"). Schedule A attached hereto sets forth information referred to in Instruction C of Schedule 13D with respect to each Reporting Person, other than Mr. Atwood.

(b)

The principal business address of each of the Reporting Persons is 5000 Riverside Drive, Suite 100E, Building 6, Irving, TX 75039.

(c)

The principal business of each of the Reporting Persons, other than Atwood and Holdings, is to invest in securities and other assets. The principal business of Holdings is to serve as the manager of the eQuine entities. The principal business of Atwood is to serve as the Chief Executive Manager of the other Reporting Persons.

(d), (e)

During the last five years, none of the Reporting Persons or any person listed on Schedule A (i) have been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding any violation with respect to such laws.

(f)

Atwood is a citizen of the United States of America.

Item 3. Source and Amount of Funds or Other Consideration

Item 3 of this Schedule 13D is supplemented as follows:

Each of the Reporting Persons, other than Atwood and Holdings, is a private equity fund formed for the purpose of making investments for its own account. The source of funds for such Reporting Persons is capital committed by the members of such Reporting Persons.

The Reporting Persons purchased the Subject Shares in the transactions listed on Exhibit 99.2 for aggregate consideration (excluding brokerage commissions) of approximately $36,000.

Item 4. Purpose of Transaction

Item 4 of this Schedule 13D is supplemented and superseded, as the case may be, as follows:

This Amendment is being filed to report the disposition of all of the Common Shares held as a group by the Reporting Persons. The Reporting Persons as a group are no longer the beneficial owners of five percent or more of the Issuer's Common Stock, and so this Amendment constitutes an "exit filing" with respect to this Schedule 13D by the Reporting Persons.

Item 5. Interest in Securities of the Issuer

Item 5 is hereby amended and restated as follows:

(a), (b)

As of February 25, 2020, the Reporting Persons (and each of them) beneficially own no Common Shares.

(c)

Exhibit 99.2, which is incorporated by reference into this Item 5(c) as if restated in full, describes all of the transactions in the Common Shares that were effected in the past 60 days by the Reporting Persons.

(d)

No other person is known to the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Subject Shares.

(e)

The Reporting Persons have ceased to be the beneficial owners of more than five percent of the Company's Common Shares.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Except for the matters described herein, the Reporting Persons do not have any contract, arrangement, understanding or relationship (legal or otherwise) with any person with respect to the securities of the Issuer.

Item 7. Material to Be filed as Exhibits

Exhibit No.	Description

99.1	Joint Filing Agreement

99.2	Trading Data

Signature

After reasonable inquiry and to the best of each of the undersigned's knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct.

Date: March 6, 2020	EQUINE HOLDINGS, LLC

	By: /s/ John Cooley Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	EQUINE HOLDINGS CHARTER PRIVATE EQUITY FUND XIII 13

	By: /s/ John Cooley
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	EQUINE CHARTER PRIVATE EQUITY FUND XX

	By: /s/ John Cooley
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	EQUINE CHARTER PRIVATE EQUITY FUND XI

	By: /s/ John Cooley
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	EQUINE CHARTER PRIVATE EQUITY FUND XII

	By: /s/ John Cooley
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	EQUINE CHARTER PRIVATE EQUITY FUND XV, LLC

	By: /s/ John Cooley
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020

EQUINE CHARTER PRIVATE EQUITY FUND DCCCLXXXVIII, LLC


	By: /s/ John Cooley
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	EQUINE CHARTER PRIVATE EQUITY FUND VII, LLC

	By: /s/ John Cooley
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	EQUINE PRIVATE EQUITY FUND 755460, LLC

	By: /s/ John Cooley
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	GODDARD INVESTMENT COMPANY PE FUND XIX

	By: /s/ John Cooley___________________
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	EQUINE PRIVATE EQUITY FUND LXXVII (77) LLC

	By: /s/ John Cooley___________________
	Name: John Cooley
	Title: Chief Financial Manager

Date: March 6, 2020	By: /s/ Brent Atwood
	Name: Brent Atwood

SCHEDULE A

Brent Atwood is the Chief Executive Manager of each of the entities listed as Reporting Persons. Mr. Atwood's principal business address is 5000 Riverside Drive, Suite 100E, Building 6, Irving, TX 75039. Mr. Atwood's principal business is as a businessman.

John Cooley is the Chief Financial Manager of each of the entities listed as Reporting Persons. Mr. Cooley's principal business address is 5000 Riverside Drive, Suite 100E, Building 6, Irving, TX 75039. Mr. Cooley's principal business is as a businessman. Mr. Cooley is a citizen of the United States of America.

Holdings is a 1% member of all of the reporting entities. Brent Atwood is the Chief Executive Manager of all of the entities, including Holdings. John Cooley is the Chief Financial Manager of all of the entities including Holdings. There is a tiered sharing of profits between Holdings and the subsidiary entities.

Sec Form 13D Filing - Atwood Brent filing for GLOBESTAR THERAPEUTICS CORP (GSTC) - 2020-03-06